We found 6 drugmaker programs for IgA Nephropathy medicines and 5 charity funds (3 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for IgA Nephropathy depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Medical and medication costs.
Covers: Insurance premiums and copays.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Out-of-pocket medical costs and non-medical costs of treatment such as childcare or transportation (Foundation membership required).
Covers: Copays, premiums or other treatment costs.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Co-Pay Plus: eligible privately insured patients may pay as little as $0; up to $20,000 a year for Fabhalta plus up to $1,000 for required vaccinations. Not for government insurance.
Privately insured patients with a prior authorization or initial denial may get up to 12 months of Fabhalta free while coverage is pursued.
A dedicated Novartis Patient Support team helps with coverage and ongoing support. Mon-Fri 8 AM-8 PM ET.
Novartis Patient Assistance Foundation provides Fabhalta free to eligible patients who are uninsured or have government insurance and meet income limits.
Free drug is through the separate Novartis Patient Assistance Foundation (1-800-277-2254); income limits apply.
$0 copay program for eligible commercially insured patients; annual maximum benefit applies.
Dedicated Nurse Educator helps with starting treatment, financial support, refills, and help for government-insured and uninsured patients.
REMS liver lab testing at home at no cost for eligible patients.
Uninsured patients: nurse educator checks whether more support is available.
Eligible commercially insured US patients may pay as little as $0 for their Tarpeyo prescription.
Care Navigators help with financial support options, refills and home delivery; pharmacists check in during the 9-month course.
Tarpeyo is dispensed only through PANTHERx Rare Pharmacy.
Eligible commercially insured patients may pay as little as $0. Annual maximum applies. Not valid with Medicare, Medicare Advantage, Medicaid or TRICARE.
Patient Assistance Program may provide TRUTAKNA at no cost to uninsured or underinsured US residents who meet household income limits. Not for government-insured prescriptions.
Bridge Program may give commercially insured patients a 28-day supply during insurance coverage delays; more refills only while actively pursuing coverage.
Case Managers help you understand your insurance benefits and tell your doctor's office how to complete any prior authorization; Nurse Educators explain how to take the medicine.
You can only enroll in Tru Support through your healthcare provider. Case Managers answer Monday to Friday, 8 am to 8 pm ET.
Co-Pay Plus: eligible privately insured patients may pay as little as $0; combined annual limit up to $15,000. Not for Medicare, Medicaid, TRICARE, VA or DoD.
Bridge Program: privately insured patients with a prior authorization or initial denial may get Vanrafia free for up to 12 months or until coverage is approved.
Novartis Patient Support answers insurance coverage questions and gives ongoing support. Mon-Fri 8 AM-8 PM ET.
Novartis Patient Assistance Foundation provides Vanrafia free to eligible patients who are uninsured or have government insurance and meet income limits.
Free drug is through the separate Novartis Patient Assistance Foundation (1-800-277-2254); income limits apply. The Bridge Program requires a prior authorization or appeal to be filed within 45 days.
VOYXACT Copay Program: eligible commercially insured patients may pay as little as $0; annual maximum benefit applies. No copay card needed.
VOYXACT Bridge Program: commercially insured patients facing a coverage delay may get up to three 28-day supplies at no cost.
An Otsuka Care Navigator provides education and help getting started, including using the prefilled syringe.
Otsuka Patient Assistance Foundation lists VOYXACT among medications it provides free to eligible uninsured or underinsured patients.
Copay and bridge programs exclude Medicare, Medicaid, VA, DoD, TRICARE and other government programs. Free drug is through the separate Otsuka Patient Assistance Foundation (1-855-727-6274).
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 6 drugmaker programs for IgA Nephropathy medicines and 5 charity funds, 3 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For IgA Nephropathy, 0 charity funds on this page accept Medicare, and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, NORD RareCare's IgA Nephropathy Medical Assistance fund, NORD RareCare's IgA Nephropathy Premium Copay Assistance fund, The Assistance Fund's Immunoglobulin A Nephropathy (IgAN) fund were open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for IgA Nephropathy medicines, 4 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (NORD RareCare, The Assistance Fund, IgA Nephropathy Foundation, HealthWell Foundation) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
